© Copyright 2025 American Medical Association. All rights reserved.
The procedure described by CPT® Code 0739T involves the ablation of malignant prostate tissue using a magnetic field induction technique. This innovative approach utilizes a suspension of magnetic nanoparticles that are injected into targeted areas of the prostate tissue. The procedure is designed to effectively destroy tumor cells while preserving surrounding healthy tissue. During the ablation process, the patient remains conscious, allowing them to communicate their sensations and comfort levels to the physician, which is crucial for ensuring patient safety and comfort throughout the procedure. The physician relies on preoperative imaging, such as MRI, along with ultrasound guidance, to accurately place the necessary catheters that will hold temperature sensors for real-time monitoring during the treatment. The procedure also includes bladder irrigation, which is initiated to protect the bladder during the injection of the nanoparticle suspension. This irrigation continues until it is confirmed that no nanoparticles are present in the urethra, indicating that the procedure can proceed safely. The temperature sensors are strategically placed through the catheters to monitor the tissue temperature closely, ensuring that it remains within the target range necessary for effective ablation. The magnetic field is activated for approximately one hour, during which the physician continuously monitors the tissue temperatures to achieve successful tumor ablation.
© Copyright 2025 Coding Ahead. All rights reserved.
The procedure described by CPT® Code 0739T is indicated for the treatment of malignant prostate tissue. This technique is specifically utilized for patients diagnosed with prostate cancer, where traditional treatment options may not be suitable or effective. The use of magnetic field induction for ablation is particularly relevant for tumors that are localized within the prostate and can benefit from targeted thermal destruction while minimizing damage to surrounding healthy tissue.
The procedure for CPT® Code 0739T involves several critical steps to ensure effective ablation of malignant prostate tissue. Each step is meticulously planned and executed to maximize patient safety and treatment efficacy.
Following the completion of the ablation procedure, patients are monitored for any immediate post-procedural effects. It is essential to assess the patient's comfort level and any potential complications that may arise from the procedure. The physician will typically provide instructions regarding post-procedure care, which may include recommendations for hydration, activity restrictions, and follow-up appointments to evaluate the effectiveness of the treatment. Additionally, monitoring for any signs of infection or adverse reactions is crucial in the days following the procedure to ensure patient safety and recovery.
Short Descr | ABLTJ MAL PRST8 MAG FLD NDCT | Medium Descr | ABLATION MAL PRST8 TISS MAGNETIC FIELD INDUCTION | Long Descr | Ablation of malignant prostate tissue by magnetic field induction, including all intraprocedural, transperineal needle/catheter placement for nanoparticle installation and intraprocedural temperature monitoring, thermal dosimetry, bladder irrigation, and magnetic field nanoparticle activation | Status Code | Carriers Price the Code | Global Days | YYY - Carrier Determines Whether Global Concept Applies | PC/TC Indicator (26, TC) | 0 - Physician Service Code | Multiple Procedures (51) | 2 - Standard payment adjustment rules for multiple procedures apply. | Bilateral Surgery (50) | 0 - 150% payment adjustment for bilateral procedures does NOT apply. | Physician Supervisions | 09 - Concept does not apply. | Assistant Surgeon (80, 82) | 2 - Payment restriction for assistants at surgery does not apply to this procedure... | Co-Surgeons (62) | 0 - Co-surgeons not permitted for this procedure. | Team Surgery (66) | 0 - Team surgeons not permitted for this procedure. | Diagnostic Imaging Family | 99 - Concept Does Not Apply | APC Status Indicator | Non-Covered Service, not paid under OPPS | Berenson-Eggers TOS (BETOS) | none | MUE | 1 |
Date
|
Action
|
Notes
|
---|---|---|
2023-01-01 | Added | Code added. |
Get instant expert-level medical coding assistance.